Benzinga's Top Pre-Market Gainers
WSI Industries (NASDAQ: WSCI) surged 32.92% to $6.50 in the pre-market session. WSI Industries reported a 51% surge in its Q3 net income.
Gevo (NASDAQ: GEVO) added 18.24% to $7.00 in the pre-market session. Analysts at Cowen upgraded Gevo from “neutral” to “outperform.”
Idenix Pharmaceuticals (NASDAQ: IDIX) moved up 12.06% to $10.50 in the pre-market session. Idenix Pharma reported positive clinical data for HCV drug candidates IDX184 and IDX719.
Arena Pharmaceuticals (NASDAQ: ARNA) soared 5.05% to $10.19 in the pre-market trading. The Food and Drug Administration is scheduled to make a decision on the company's experimental obesity drug lorcaserin by June 27.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.